Advancements in drug therapies and clinical care strategies highlight today's medical landscape.

The FDA has approved the PD-1 inhibitor dostarlimab for the treatment of rectal cancer, offering a potential path for patients to avoid invasive procedures like surgery, radiation, and chemotherapy.

New FDA approval for Ryzumvi eye drops marks a shift in treating pharmacologically induced mydriasis in adults and children three years and older.

Pediatric clinicians are being encouraged to integrate the MENSES mnemonic into routine check-ups to better evaluate and manage adolescent menstrual health.

Research indicates that high-dose budesonide tablets effectively reduce the formation of esophageal strictures following extensive endoscopic submucosal dissection.

Leading researchers are exploring a potential correlation between olfactory loss and the rising prevalence of obesity and type 2 diabetes.

Surgeons working in conflict zones like Gaza are forced to make difficult clinical decisions, balancing the risks of limb salvage versus amputation amidst severe resource limitations.

A growing trend of medical school applicants taking gap years is receiving increased support from academic leaders who recognize the potential benefits for student preparedness.

Debate is intensifying in Alberta over a dual-practice model that allows doctors to work in both public and private systems, with critics raising concerns about health equity and increased wait times.